Cardiovascular complications of antineoplastic treatment in prostate cancer patients and compensatory strategies for clinical management
{{output}}
Prostate cancer (PCa) is one of the most common malignancies among men worldwide. Advances in systemic therapies, including androgen deprivation therapy (ADT), androgen receptor-targeted agents, chemotherapy, poly(ADP-ribose) polymerase (PARP) inhibitors, and ... ...
